Fangdi Wei
Papers
1
Total Citations
16
H-Index
1
About
Fangdi Wei is a rising innovator at the intersection of CRISPR-based biosensing and DNA nanotechnology. Their research centers on engineering programmable DNA architectures to precisely control the trans-cleavage activity of Cas12a, a cornerstone of modern molecular diagnostics. Wei’s most-cited work introduces “DNA robots” that act as modular switches, enabling universal biosensing platforms with enhanced specificity and signal amplification. This approach overcomes a key limitation in the field—the difficulty of managing Cas12a’s activity through simple modifications—by leveraging dynamic DNA structures to regulate enzyme function. With 16 citations since 2024, this foundational paper is already shaping next-generation diagnostic tools for pathogens, genetic markers, and beyond. Wei’s contributions stand out for their elegant simplicity: rather than complex chemical modifications, they use the inherent programmability of DNA to build responsive, tunable systems. This work not only advances CRISPR-based sensing but also opens new avenues for smart therapeutics and point-of-care devices. For students and researchers, Wei exemplifies how creative DNA engineering can unlock the full potential of CRISPR technology for real-world applications.
Research Focus
Key Achievements
Top Papers
- 1